Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification
R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …
[HTML][HTML] The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
NAJ Ryan, MA Glaire, D Blake, M Cabrera-Dandy… - Genetics in …, 2019 - Elsevier
Purpose Endometrial cancer (EC) is often the sentinel cancer in women with Lynch
syndrome (LS). However, efforts to implement universal LS screening in EC patients have …
syndrome (LS). However, efforts to implement universal LS screening in EC patients have …
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the …
C Cremolini, C Antoniotti, D Rossini, S Lonardi… - The Lancet …, 2020 - thelancet.com
Background The triplet FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus
bevacizumab showed improved outcomes for patients with metastatic colorectal cancer …
bevacizumab showed improved outcomes for patients with metastatic colorectal cancer …
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and …
C Cremolini, F Loupakis, C Antoniotti, C Lupi… - The Lancet …, 2015 - thelancet.com
Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and
irinotecan) plus bevacizumab significantly improved progression-free survival of patients …
irinotecan) plus bevacizumab significantly improved progression-free survival of patients …
Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma
Purpose Deleterious germline mutations contribute to pancreatic cancer susceptibility and
are well documented in families in which multiple members have had pancreatic cancer …
are well documented in families in which multiple members have had pancreatic cancer …
Cancer Risks for PMS2-Associated Lynch Syndrome
SW Ten Broeke, HM van der Klift, CMJ Tops… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Lynch syndrome due to pathogenic variants in the DNA mismatch repair genes
MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial …
MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial …
Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations
P Dinarvand, EP Davaro, JV Doan… - … of pathology & …, 2019 - meridian.allenpress.com
Context.—Familial adenomatous polyposis (FAP) is a rare genetic disorder with autosomal
dominant inheritance, defined by numerous adenomatous polyps, which inevitably progress …
dominant inheritance, defined by numerous adenomatous polyps, which inevitably progress …
The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment
Opinion statement Colorectal cancer (CRC) is the third leading cancer diagnosed globally
and an important cause of cancer-related mortality. Of interest, while we have witnessed a …
and an important cause of cancer-related mortality. Of interest, while we have witnessed a …
Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management
P Kanth, J Grimmett, M Champine, R Burt… - Official journal of the …, 2017 - journals.lww.com
Colorectal cancer (CRC) is the fourth most common cancer amongst men and women.
Between 3 and 6% of all CRCs are attributed to well-defined inherited syndromes, including …
Between 3 and 6% of all CRCs are attributed to well-defined inherited syndromes, including …
Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017
VN Giri, KE Knudsen, WK Kelly, W Abida… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Guidelines are limited for genetic testing for prostate cancer (PCA). The goal of this
conference was to develop an expert consensus-driven working framework for …
conference was to develop an expert consensus-driven working framework for …